Potent T cell response to a class I‐binding 13‐mer viral epitope and the influence of HLA micropolymorphism in controlling epitope length
Kate J. Green(QIMR Berghofer Medical Research Institute), Scott R. Burrows(Australian National University), Geoff Connolly(QIMR Berghofer Medical Research Institute), Judy Tellam(QIMR Berghofer Medical Research Institute), Wendy J. M. van Zuylen(QIMR Berghofer Medical Research Institute), John J. Miles(University of Cambridge)
Cited by 50
Related Papers
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
|The Journal of Experimental Medicine|1992|391
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
|Proceedings of the National Academy of Sciences|1999|332
A Structural Basis for the Selection of Dominant αβ T Cell Receptors in Antiviral Immunity
|Immunity|2003|323
Estimating the global burden of Epstein–Barr virus-related cancers
|Journal of Cancer Research and Clinical Oncology|2021|313